bioengineer.org /3 weeks ago

Chalcone compound UR-2 kills stem-like lung cancer cells by disrupting mitochondrial redox signaling

A hydroxylated chalcone derivative called UR-2 suppressed the growth of CD133-positive lung cancer organoids by lowering Thioredoxin-2 expression and triggering mitochondrial apopt...

Read source
bioengineer.org /1 week ago

CLDN6 Promotes Colorectal Cancer Liver Metastasis via Distinct Signaling and Epigenetic Reprogramming

Researchers identified the surface marker CLDN6 as a driver of liver metastasis in aggressive consensus molecular subtype 4 colorectal cancer across multi-omics datasets and precli...

Read source
qchron.com /1 month ago

ESMO 2026 Preview | Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Nega...

SHANGHAI, Oct. 18, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present Phase II...

Read source
bioengineer.org /1 week ago

FADS1 Identified as Candidate Biomarker for MASH and Early-Onset Colorectal Cancer

Researchers have identified FADS1 as a candidate shared biomarker linking metabolic dysfunction-associated steatohepatitis to early-onset colorectal cancer through machine learning...

Read source
seekingalpha.com /6 days ago

Ideaya picks cancer drug candidate, targets human trial application in 2027

Read source
labiotech.eu /1 month ago

B7-H3 ADCs: A new contender in small cell lung cancer and beyond 

Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer as Hansoh Pharma and Medilink bring momentum with positive results. The post B7-H3 ADCs: A new contender in small...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.